Patent intelligence · US
US 2021186075
COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINS, AND RELATED FOOD PRODUCT METHODS AND SYSTEMS
COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINS, AND RELATED FOOD P…
Patent details — US 2021186075
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 24, 2021
- Expiration
- Jun 19, 2041
- Applicant
- SOFAR SPA [IT]
- CPC classes
- A61K 35/ 747 A I, A61K/35745, A61K/35747, A61K/4506
Quick answer
US 2021186075 (COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINS, AND RELATED FOOD PRODUCT METHODS AND SYSTEMS) is held by SOFAR SPA [IT]. Status: granted. Granted Jun 24, 2021. Expires Jun 19, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SOFAR SPA [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 35/ 747 A I, A61K/35745, A61K/35747, A61K/4506
More from SOFAR SPA [IT]
Related pharmaceutical patents in our USPTO index.
-
WO 2026027669
BIOMARQUEURS POUR DÉTERMINER LE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AVEC DU FILGOTINIB
granted -
IT 202300014295
COMPOSIZIONI ORODISPERSIBILI COMPRENDENTI BETAMETASONE FOSFATO
granted -
IT 202300012522
FLUOROMETIL-CARNITINA PER USO COME INIBITORE DI COLINA TRIMETILAMMINA (TMA) LIASI.
granted -
AU 2023257308
USES OF FARNESOID X RECEPTOR AGONISTS
granted -
IT 202300006237
COMPOSIZIONI NUTRACEUTICHE PER IL TRATTAMENTO O PREVENZIONE DI DISORDINI CONNESSI ALLA TRIMETILAMINURIA.
granted -
IT 202300001434
PRODOTTO DI FERMENTAZIONE PER USO NEL TRATTAMENTO DI PATOLOGIE ASSOCIATE ALLA SINDROME METABOLICA E STEATOSI EPATICA.
granted -
CA 3263063
VELUSETRAG DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE LA PSEUDO-OBSTRUCTION INTESTINALE CHRONIQUE (POIC)
granted -
IT 202200013882
PRODOTTO DI FERMENTAZIONE PER IL TRATTAMENTO DI MALATTIE INFIAMMATORIE.
granted
Frequently asked questions
What is US patent 2021186075?
US 2021186075 (COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINS, AND RELATED FOOD PRODUCT METHODS AND SYSTEMS) is held by SOFAR SPA [IT]. Status: granted. Granted Jun 24, 2021. Expires Jun 19, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2021186075?
SOFAR SPA [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2021186075 expire?
Our index shows an expiration date of Jun 19, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.